Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Revenues, net:    
Product $ 8,537,170 $ 6,654,282
Recurring 4,221,206 4,526,680
Total Net Revenue 12,758,376 11,180,962
Product 4,726,241 3,820,753
Recurring 1,178,077 1,146,252
Total Cost of Sales 5,904,318 4,967,005
Gross Profit 6,854,058 6,213,957
Operating Expenses:    
Research and development 984,853 775,329
Selling, general and administrative 5,238,700 4,652,527
Impairment of goodwill    3,100,000
Depreciation and amortization 260,830 268,575
Total Operating Expense 6,484,383 8,796,431
Income (Loss) from Operations 369,675 (2,582,474)
Interest expense, net (26,274) (263,702)
Gain on derivative liability    172,476
Gain on disposal of property and equipment    2,165
Gain on sale of product line 15,408 829,296
Total Other (Expenses) Income (10,866) 740,235
Income (Loss) Before Provision for Income Taxes 358,809 (1,842,239)
(Benefit) Provision for Income Taxes (31,271) 60,000
Net Income (Loss) 390,080 (1,902,239)
Accretion of preferred dividends and discount (897,638) (699,895)
Net income (loss) attributable to common stockholders $ (507,558) $ (2,602,134)
Net income (loss) per common share:    
Income loss per common share - basic $ 0 $ (0.02)
Income loss per common share - diluted $ 0 $ (0.02)
Weighted Average Common Shares Outstanding - basic 105,788,739 102,570,300
Weighted Average Common Shares Outstanding - diluted 107,387,408 103,815,367